Orion recommits to profitability target, R&D amid share price slump

Auckland-based health IT firm Orion Health is still aiming to be profitable in the 2018 financial year and has recommitted to its R&D program despite forecasting lower than expected operating revenue for the current year, which saw its share price slump by 14.5 per cent.

Orion Health, which listed on both the New Zealand and Australian stock exchanges in late 2014 at an initial price of $NZ5.70, is trading at about $1.42 today. It had been trading steadily last year at about $3.50.